Steward Partners Investment Advisory, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2023$12,870
+34.5%
11,0000.0%0.00%
Q3 2023$9,569
-22.3%
11,0000.0%0.00%
Q2 2023$12,320
+7.7%
11,0000.0%0.00%
Q1 2023$11,440
-7.1%
11,0000.0%0.00%
Q4 2022$12,32011,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,750,107$10,875,0000.41%
Plante Moran Financial Advisors, LLC 50,000$145,0000.05%
Donald L. Hagan, LLC 14,000$40,0000.04%
Game Plan Financial Advisors, LLC 11,000$32,0000.03%
Tekla Capital Management LLC 165,330$479,0000.02%
Virtu Financial LLC 52,655$153,0000.02%
SIGNATUREFD, LLC 58,326$169,0000.01%
OXFORD ASSET MANAGEMENT LLP 131,783$382,0000.01%
Lindbrook Capital, LLC 10,000$29,0000.01%
WEDBUSH SECURITIES INC 40,700$118,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders